ChestLink
Generate reports from chest X-rays through an automated reading workflow.
Oxipit Funding History
Oxipit develops AI for medical imaging. Its ChestLink software can report on chest X-rays autonomously and was the first tool of its kind to receive a CE mark.
Company Overview
Oxipit
Vilnius, Lithuania
Official WebsiteOxipit Funding Timeline
Acquisition
Terms undisclosed
Sectra said the acquisition added Oxipit’s autonomous chest X-ray analysis technology to its diagnostic imaging business.
Led by Sectra.
Source · sectra.com ↗
Oxipit Founding Team
Gediminas Peksys and a team of medical and data science specialists in Vilnius built Oxipit around a question in radiology: could software identify normal chest X-rays reliably enough to let radiologists focus on more complex cases? The team included radiologist and co-founder Naglis Ramanauskas.
Oxipit Products
Oxipit Company Development
Autonomous Chest Reporting Enters Sectra
Oxipit developed ChestLink for autonomous reporting on chest X-rays. Sectra completed its acquisition in April 2026, bringing Oxipit’s approach to reporting into a vendor that already supplies diagnostic imaging systems.
Oxipit Competitive Landscape
Autonomous Reports and Reader Assistance
Oxipit’s ChestLink automates reporting for chest X-rays within its intended use. Gleamer’s BoneView helps readers detect possible fractures on X-rays. The products illustrate separate deployment questions for imaging teams: which studies can follow an automated path, and where the radiologist needs decision support.
